Boston Scientific CEO says Congress should repeal device excise tax

07/5/2011 | Star Tribune (Minneapolis-St. Paul, Minn.)

Congress should work to rescind the 2.3% excise tax on medical devices in the health care law because it will stifle innovation and job growth, Boston Scientific President and CEO Ray Elliott writes in this Star Tribune opinion. Repealing the tax "would help protect the 2 million Americans whose jobs are supported by the medical technology sector and remove burdens on a uniquely American industry that collectively spends more than $10 billion annually on R&D, boasts a net trade surplus and has historically led the world in developing leading-edge medical technologies," Elliott writes.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ